New Key Statistics Module, Z-Score and F-Score
BKK:BIOTEC Key Ratios
| Market Cap ฿ M | 824.41 |
| Enterprise Value ฿ M | 1,771.83 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.68 |
| Price/Sales | 0.17 |
| Price/Free Cash Flow | 4.22 |
| Price/Owner Earnings | 6.22 |
| Payout Ratio % | -- |
| Revenue (TTM) ฿ M | 4,827.00 |
| EPS (TTM) ฿ | -0.03 |
| Beneish M-Score | -2.26 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -46.70 |
| EV-to-EBIT | 369.43 |
| EV-to-EBITDA | 12.20 |
| PEG | -- |
| Shares Outstanding M | 3,053.36 |
| Net Margin (%) | -1.89 |
| Operating Margin % | -0.47 |
| Pre-tax Margin (%) | -1.32 |
| Quick Ratio | 0.58 |
| Current Ratio | 0.75 |
| ROA % (ttm) | -3.01 |
| ROE % (ttm) | -7.46 |
| ROIC % (ttm) | -1.10 |
| Dividend Yield % | -- |
| Altman Z-Score | 1.53 |
BKK:BIOTEC Number of Guru Trades
BKK:BIOTEC Volume of Guru Trades
Gurus Latest Trades with BKK:BIOTEC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
BKK:BIOTEC is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers